Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

1.5K Views

06:08 min

June 2nd, 2023

DOI :

10.3791/64623-v

June 2nd, 2023


Transcript

Explore More Videos

Patient derived Xenograft

Chapters in this video

0:04

Introduction

1:03

Tumor Transplantation and Preservation

2:49

Resuscitation of Patient-Derived Xenograft (PDX) Model Tumors

3:57

Results: Tumor Growth Assessment & Effect of Lenvatinib and Cisplatin on PDX Model Tumors

5:28

Conclusion

Related Videos

article

08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

10.4K Views

article

07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

9.5K Views

article

06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

9.6K Views

article

08:15

Fabrication of Tongue Extracellular Matrix and Reconstitution of Tongue Squamous Cell Carcinoma In Vitro

6.1K Views

article

07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

11.3K Views

article

09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

10.0K Views

article

08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

9.6K Views

article

08:43

Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models

11.1K Views

article

07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

7.0K Views

article

06:52

The Establishment and Utilization of Patient Derived Xenograft Models of Central Nervous System Metastasis

2.2K Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved